Matching comparisons of therapeutic efficacy suggest better clinical outcomes for patients treated with peginterferon beta-1a than with glatiramer acetate

por Scott, Thomas F., Su, Ray, Xiong, Kuangnan, Altincatal, Arman, Castrillo-Viguera, Carmen, Naylor, Maria L.
Publicado 2021

Preliminary study: Treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2(+ )and decreased levels of IL23R(+ )CD4(+ )T - Lymphocytes in multiple sc...

por Kress-Bennett, Jennifer M, Ehrlich, Garth D, Bruno, Ashley, Post, J Christopher, Hu, Fen Z, Scott, Thomas F
Publicado 2011

Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosis

por Scott, Thomas F, Kieseier, Bernd C, Newsome, Scott D, Arnold, Douglas L, You, Xiaojun, Hung, Serena, Sperling, Bjoern
Publicado 2016

Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study, ATTAIN

por Newsome, Scott D., Scott, Thomas F., Arnold, Douglas L., Nelles, Gereon, Hung, Serena, Cui, Yue, Shang, Shulian, Naylor, Maria L., Kremenchutzky, Marcelo
Publicado 2018